A Bioequivalence Study of Capecitabine Tablets
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
1. purpose: To conduct the relative bioavalability study of Capecitabine tablets 500 mg (Jiangsu Chia-Tai Tianqing Pharmacy Co. Ltd.) versus XELODA 500 mg tablets (Manufactured by Roche Pharma AG) 2. Experimental Design： Two-period crossover design 3. Test drug: Capecitabine tablets Reference drug: XELODA 4. Sample size：24
创建时间：
2012-12-15
